2020-12-14
Camurus announced on December 10, 2020, that the ICC International Court of Arbitration has issued a partial award in the arbitration process between Camurus and Braeburn regarding the parties’ license agreement for the development and commercialization of CAM2038 in North America.
Read the full press release on Camurus' website: https://www.camurus.com/
2020-07-16
”For the fourth quarter in a row, we saw Buvidal® sales growth of more than 50%”
Read more2020-06-24
Positive results from Phase 2 study of once-weekly FluidCrystal® formulation of setmelanotide in healthy volunteers…
Read more2020-06-23
The improvements are driven by increasing market shares of Buvidal® for treatment of opioid dependence in Europe and…
Read more2020-05-07
”The number of patients treated with Buvidal® increased by 90 percent in the quarter”
Read more2020-04-08
Camurus Annual Report for 2019 is now available at the company´s website.
Read more